2026 Johannes Zuber: Biology and Biochemistry Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Biology and Biochemistry	74	5489	5062	44	43	237	25841

Overview

Johannes Zuber is affiliated with the Research Institute of Molecular Pathology in Austria. Their research contributions span extensively within the fields of biochemistry, genetics, molecular biology, and medicine.

Their work is predominantly situated in several subfields of study, including:

Molecular Biology
Hematology
Oncology
Infectious Diseases
Immunology

Key topics addressed in their research encompass:

Acute Myeloid Leukemia Research
Protein Degradation and Inhibitors
Ubiquitin and proteasome pathways
CRISPR and Genetic Engineering
Advanced biosensing and bioanalysis techniques
Genomics and Chromatin Dynamics
RNA Research and Splicing

Johannes Zuber has authored multiple scientific papers published in notable venues. Selected recent publications include:

"Rational discovery of molecular glue degraders via scalable chemical profiling", 2020, Nature Chemical Biology
"Acquired resistance to anti-MAPK targeted therapy confers an immune-evasive tumor microenvironment and cross-resistance to immunotherapy in melanoma", 2021, Nature Cancer
"Cohesin-Dependent and -Independent Mechanisms Mediate Chromosomal Contacts between Promoters and Enhancers", 2020, Cell Reports
"A human tissue screen identifies a regulator of ER secretion as a brain-size determinant", 2020, Science
"Functional interrogation of a SARS-CoV-2 host protein interactome identifies unique and shared coronavirus host factors", 2020, Cell Host & Microbe

Their frequent co-authors include:

Michaela Fellner
Julian Jude
Tobias Neumann
Matthias Hinterndorfer
Florian Andersch

The most common publication venues for their work are:

bioRxiv (Cold Spring Harbor Laboratory)
Blood
Nature Communications
Cancer Research
HemaSphere

Best Publications

RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia

Johannes Zuber;Junwei Shi;Junwei Shi;Eric Wang;Amy R. Rappaport;Amy R. Rappaport

2080
Citations
Senescence-associated reprogramming promotes cancer stemness

Maja Milanovic;Dorothy N. Y. Fan;Dimitri Belenki;J. Henry M. Däbritz

910
Citations
Cancer stem cell definitions and terminology: the devil is in the details

Peter Valent;Dominique Bonnet;Ruggero De Maria;Tsvee Lapidot

802
Citations
Toward understanding and exploiting tumor heterogeneity

Ash A Alizadeh;Victoria Aranda;Alberto Bardelli;Cedric Blanpain

778
Citations
Topologically associating domains and chromatin loops depend on cohesin and are regulated by CTCF, WAPL, and PDS5 proteins

Gordana Wutz;Csilla Várnai;Kota Nagasaka;David A Cisneros

735
Citations
An Optimized microRNA Backbone for Effective Single-Copy RNAi

Christof Fellmann;Thomas Hoffmann;Vaishali Sridhar;Barbara Hopfgartner

731
Citations
Human blood vessel organoids as a model of diabetic vasculopathy

Reiner A. Wimmer;Alexandra Leopoldi;Martin Aichinger;Nikolaus Wick

609
Citations
Thiol-linked alkylation of RNA to assess expression dynamics.

Veronika A Herzog;Brian Reichholf;Tobias Neumann;Philipp Rescheneder

508
Citations
An Oncogenomics-Based In Vivo RNAi Screen Identifies Tumor Suppressors in Liver Cancer

Lars Zender;Wen Xue;Johannes Zuber;Camile P. Semighini

506
Citations
Transcriptional plasticity promotes primary and acquired resistance to BET inhibition

Philipp Rathert;Mareike Roth;Tobias Neumann;Felix Muerdter

495
Citations
Role of SWI/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation

Junwei Shi;Warren A. Whyte;Cinthya J. Zepeda-Mendoza;Cinthya J. Zepeda-Mendoza;Joseph P. Milazzo

467
Citations
Anti-apoptotic Mcl-1 is essential for the development and sustained growth of acute myeloid leukemia

Stefan P. Glaser;Erinna F. Lee;Evelyn Trounson;Philippe Bouillet

447
Citations
Necroptosis microenvironment directs lineage commitment in liver cancer

Marco Seehawer;Florian Heinzmann;Luana D’Artista;Jule Harbig

436
Citations
Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T-cell acute lymphoblastic leukaemia

Konstantinos J. Mavrakis;Andrew L. Wolfe;Andrew L. Wolfe;Elisa Oricchio;Teresa Palomero

419
Citations
A genome-wide survey of RAS transformation targets

Johannes Zuber;Oleg I. Tchernitsa;Bernd Hinzmann;Anne-Chantal Schmitz

359
Citations
A rapid and scalable system for studying gene function in mice using conditional RNA interference.

Prem K Premsrirut;Prem K Premsrirut;Lukas E Dow;Sang Yong Kim;Matthew Camiolo;Matthew Camiolo

353
Citations
Integrative analysis of pooled CRISPR genetic screens using MAGeCKFlute.

Binbin Wang;Mei Wang;Wubing Zhang;Tengfei Xiao

342
Citations
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis

Matthias Muhar;Anna Ebert;Tobias Neumann;Christian Umkehrer

340
Citations
MLL3 is a haploinsufficient 7q tumor suppressor in acute myeloid leukemia.

Chong Chen;Yu KiKi Liu;Amy R Rappaport;Thomas Kitzing

322
Citations
Mouse models of human AML accurately predict chemotherapy response

Johannes Zuber;Ina Radtke;Timothy S. Pardee;Zhen Zhao

321
Citations